, Hong Kong
109 views
Photo by Andrea Piacquadio from Pexels

CK Life Sciences to post $126.6m loss in 2024

It was due to increased research and development investments.

CK Life Sciences International expects to report a loss attributable to shareholders of $126.6m for financial year 2024, compared to a profit of $17.3m for 2023.

The company said this was due to increased research and development investments and a decline in the fair value of the vineyard portfolio.

Overall, the group said operations remained stable throughout the year. Further details will be disclosed on 18 March 2025.
 

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you design and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

Eastroc Beverage targets $10.14b in Hong Kong IPO
BlackRock and Tencent back a massive capital raise to fund aggressive international supply chain growth.
Food & Beverage
Prudential buys 19% of SHS for $375m to lift stake to 70%
Minority profit and equity attribution falls as the partner holding drops to 30%.
Insurance